Jupiter NeurosciencesJUNS
13F holders, Q3 2025 (September 30)9holders +7
7new positions
0sold out
$1.76avg. 13F price*
At the end of Q3 2025, 9 institutions reported holding Jupiter Neurosciences Inc. (JUNS) in their 13F filings, up 7 from Q2 2025. 7 opened new positions and 0 sold out. The largest holders were Vestor Capital, LLC ($1.7M), Vanguard Group Inc. ($380K) and Geode Capital Management, LLC ($183K).
- Company
- Jupiter Neurosciences Inc.
- CUSIP
- 48208B203
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $2.4M |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 1,344,369 shares bought and 49,826 shares sold, net +1,294,543 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Vestor Capital, LLC | 0.11% | New | 970,985 | $1.7M |
| Vanguard Group Inc. | 0.00% | New | 215,831 | $380K |
| Geode Capital Management, LLC | 0.00% | New | 103,815 | $183K |
| Northern Trust Corp. | 0.00% | New | 24,819 | $44K |
| XTX Topco Ltd | 0.00% | New | 15,094 | $27K |
| Citigroup Inc. | 0.00% | Add +11.8% | 12,418 | $22K |
| Jane Street Group, LLC | 0.00% | New | 12,392 | $22K |
| UBS Group AG | 0.00% | Reduce -92.4% | 4,090 | $7K |
| Bank of America Corp. | 0.00% | New | 121 | $213 |
"% of holder's portfolio" is JUNS's weight in each manager's 13F, not the share of Jupiter Neurosciences Inc. the manager owns.